US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

202.93

+0.29000.14%

Post-market: 203.020.0900+0.04%19:37 EDT

Volume:2.29M

Turnover:465.17M

Market Cap:10.28B

PE:32.15

High:205.31

Open:203.94

Low:202.75

Close:202.64

52wk High:217.12

52wk Low:138.79

Shares:50.65M

Float Shares:50.65M

Volume Ratio:1.60

T/O Rate:4.51%

Dividend:0.41

Dividend Rate:0.20%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.26

PE(LYR):-135.83

Loading ...

Overview Company News Filings

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Circio boosts circVec gene therapy data and secures funding runway to 2030

iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live

Political and General News Events from August 31

Sector Update: Healthcare

MT Newswires Live

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/IBB/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":202.93,"timestamp":1789156800000,"preClose":202.64,"halted":0,"volume":2286306,"hourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"delay":0,"changeRate":0.0014311093564943766,"floatShares":50650000,"shares":50650000,"eps":6.311863,"marketStatus":"Market Closed","change":0.29,"latestTime":"09-11 16:00:00 EDT","open":203.94,"high":205.31,"low":202.75,"amount":465174036.47682,"amplitude":0.012633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202.64,"sharesOutstanding":49450000,"nav":202.867176,"aum":10356369334.8,"dividendRate":0.001997,"bidAskSpread":0.000338,"preHourTrading":{"tag":"盘前","latestPrice":204.63,"preClose":202.64,"latestTime":"09:25 EDT","volume":602,"amount":123106.38130000001,"timestamp":1789133112066,"change":1.99,"changeRate":0.00982,"amplitude":0.017917},"postHourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"volumeRatio":1.6013834487935477,"impliedVol":0.2368,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50650000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.6013834487935477,"shares":50650000,"dividePrice":0.4053,"high":205.31,"amplitude":0.012633,"preClose":202.64,"low":202.75,"week52Low":138.785,"pbRate":"1.26","psRate":"247.29","week52High":217.12,"institutionHeld":0,"latestPrice":202.93,"eps":6.311863,"divideRate":0.001997,"volume":2286306,"delay":0,"ttmEps":6.311863,"open":203.94,"prevYearClose":168.77,"prevWeekClose":211.92,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":213.81,"twentyDayClose":198.94,"sixtyDayClose":171.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1917777945.USD","LU2089984988.USD","LU2362540622.SGD","CHAT","LU0823434740.USD","REGN","AIPO","BK4195","LU0289739699.SGD","BK4585","LU0823434583.USD","LU0823416689.USD","HBCP","LU2023250504.SGD","LU2237438978.USD","QTOC","LU2468319806.SGD","BK4588","LU2362541273.HKD","VTHR","LU0320765992.SGD","IBB","LU0114720955.EUR","LU0889565916.HKD","IBBQ","LU2106854487.HKD","LU1974910355.USD","TBXU","LU0882574055.USD","LU2362541513.USD","LU0053666078.USD","LU0109394709.USD","BK4139","LU0058720904.USD","ARTY","BBH","BK4211","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK0046","BBIO","LU0889565916.HKD","688235","IE00BJT1NW94.SGD","AMGN","TBXU","LU1883839398.USD","BK4505","300485","IE0002270589.USD","LU0321505439.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0320765992.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","BK4566","LU0306806265.USD","LU0868494617.USD","LU0225284248.USD","IE00BFTCPJ56.SGD","BK4534","OZEM","PFE","CSL.AU","BBH","BK0028","IBB","PJP","BK0012","SG9999002224.SGD","LU2112291526.USD","LU2242646821.SGD","PBE","BK7511","LU0109394709.USD","IONS","LU2468319806.SGD","IE00B3T34201.USD","BK4550","LU1983299246.USD","LU1894683348.USD","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","IE0002141913.USD","BK4007","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","CNCR","BK4588","FBT","TBXU","RNA","IBBQ","SYNB","IBB","IE0009354923.USD","BK4505","GNOM","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007498","title":"iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007498?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:46","pubTimestamp":1788198368,"startTime":"0","endTime":"0","summary":"iShares Biotechnology ETF announces Q3 2026 dividend of R$ 0.02 per unitiShares Biotechnology ETF declared a 3Q 2026 cash distribution of BRL 0.02 per unit.Units trade with entitlement through Sept. 14.Payment is scheduled for Sept. 24.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iShares Biotechnology ETF published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9CMGGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007127","title":"Sector Update: Healthcare Stocks Decline Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007127","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007127?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:37","pubTimestamp":1788197856,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower Monday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4%.The iShares Biotechnology ETF (IBB","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IYH","LU2746668974.SGD","LU1623119135.USD","LU2111349929.HKD","AGNG","LU2361044865.SGD","LU2357305700.SGD","LU0385154629.USD","LU0097036916.USD","LU0354030438.USD","LU2087625088.SGD","LU1720051108.HKD","ELIS","SG9999015952.SGD","LU2471134523.USD","LU0964807845.USD","JDOC","LU0823434740.USD","LU0820561818.USD","BK4581","SG9999017495.SGD","LU0058720904.USD","SG9999018865.SGD","LU2108987350.USD","LU2552382132.HKD","PJP","LU2746668461.USD","LU2471134952.CNY","LU2360106947.USD","LU2462591350.SGD","LU2211815571.USD","LU0786609619.USD","LU1712237335.SGD","LU2089984988.USD","PPH","SG9999014914.USD","LLY","SG9999015978.USD","IE00B1XK9C88.USD","LU1691799644.USD","LU2168563687.JPY","LU0106261372.USD","LU1629891620.HKD","LU2756315318.SGD","LU1988902786.USD","LU2112291526.USD","LU0471298777.SGD","BK4533","LU2462157665.USD","BK4588","LU1093756168.USD","LU2028103732.USD","LU2089284900.SGD","LU0061475181.USD","LU2552382215.SGD","LU0345770993.USD","MEDI","LU0238689110.USD","XBI","IE0002141913.USD","IE00BJLML261.HKD","LU1974910355.USD","LU0943347566.SGD","BK4516","IE00BN29S564.USD","LU1366192091.USD","LU0006306889.USD","IE00B4R5TH58.HKD","LU2237443622.USD","LU0823416689.USD","LU0109391861.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU1232071149.USD","IE00B2B36J28.USD","LU0158827781.USD","LU1023059063.AUD","LU1323610961.USD","MEDX","LU0234572021.USD","IE0005OL40V9.USD","IE00BK4W5L77.USD","SG9999014880.SGD","FHLC","THNR","LU2237443895.HKD","LU2271345857.HKD","LLYX","LU0198837287.USD","LU2896262040.SGD","LU1057294990.SGD","IE00BKPKM429.USD","BK4585","FTXH","MHIP","LU1127390331.HKD","LU2456880835.USD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","TMED","HRTS","CURE","LU1093756325.SGD","SGXZ51526630.SGD","LU0417517546.SGD","LU1868836914.USD","LU2461242641.AUD","LU2491050071.SGD","IE00BFSS8Q28.SGD","IE00BJJMRY28.SGD","ELIL","LU0787776722.HKD","LU2168564149.EUR","LU0353189763.USD","LU1267930730.SGD","OZEM","LU0466842654.USD","LU0882574139.USD","LU2468319806.SGD","SG9999015945.SGD","LU0323591593.USD","LU0096364046.USD","LU1868837300.USD","LU2471134879.HKD","LU1061106388.HKD","LU0256863902.USD","LU2168564495.EUR","SG9999014898.SGD","BK4007","IHE","IE00BKDWB100.SGD","IE00BJJMRX11.SGD","LU2023251221.USD","IBB","LU1064131342.USD","SGXZ31699556.SGD","SGXZ81514606.USD","LU2237438978.USD","LU1069344957.HKD","LU2750360997.AUD","LU2361044949.HKD","LU2361045086.USD","LU0133085943.USD","LU2756315664.SGD","ILDR","LU2324357040.USD","IE0004445239.USD","LU1979441026.SGD","WDNA","LU0174119429.USD","SG9999001176.SGD","LU2471134796.USD","LU1814569148.SGD","VHT","LU1917777945.USD","LU2213496289.HKD","SG9999001176.USD","LU1989771016.USD","IE00B775H168.HKD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0345770308.USD","BK4139","IE00BJJMRZ35.SGD","LU0689472784.USD","SG9999014906.USD","LU2491050154.USD","IXJ","LU0122379950.USD","SGXZ99366536.SGD","IE0009355771.USD","TRUH","LU1551013425.SGD","LU2417539215.USD","XLV","LU0256863811.USD","GDOC","LU0889565916.HKD","RXL","LU0672654240.SGD","LU0266013472.USD","LU0109394709.USD","LU0320765992.SGD","IE0004445015.USD","LU0203202063.USD","IE00B7KXQ091.USD","LU0354030511.USD","LU2750360641.GBP","SGXZ57979304.SGD","LU0471298694.HKD","LU2089283258.USD","LU1280957306.USD","LABU","LU1551013342.USD","LU0094547139.USD","LU0820561909.HKD","LU1868836591.USD","LU2552382058.USD","LU0158827948.USD","LU0225283273.USD","LU0708995401.HKD","LU1868837136.USD","LLYZ","LU2236285917.USD","LU0079474960.USD","LU0432979614.USD","LU1035775433.USD","LU0456855351.SGD","SG9999015986.USD","CANC","LU1548497426.USD","LU2023250330.USD","SG9999018857.SGD","LU1720051017.SGD","LU0353189680.USD","LU2168564222.USD","LU0316494557.USD","LU1145028129.USD","LU2063271972.USD","LU2237443382.USD","LU2237443978.SGD","BK4534","LU0882574055.USD","LU2491049909.HKD","SG9999013999.USD","LU0640476718.USD","LU0820562030.AUD","ALVO","LU1804176565.USD","LU1868836757.USD","BK4599","GB00BDT5M118.USD","LLII","LU0203201768.USD","IE0001KFT4U8.USD","LU0823434583.USD","IE00BWXC8680.SGD","LU1983299246.USD","LU2023250504.SGD","LU2106854487.HKD","LU0210536198.USD","LU0320765059.SGD","LU2265009873.SGD","LU2237443465.HKD","IE00B1BXHZ80.USD","LU0683600562.USD","LU1291159041.SGD","LU2237443549.SGD","LU2168564065.EUR","LU0114720955.EUR","LU2602419157.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663561006","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2663561006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663561006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:28","pubTimestamp":1788182880,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3%, and the actively traded Invesco QQQ Trust (QQQ) retreated 0.2% in Monday's premarket activity as the US and Iran excha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VDC","EQR","VHT.AU","XLP","VHT","PMR","DRTS","IYK","IYW","KKR","IVV","SPY","VIS","XLE","XLY","XLF","RTH.AU","FDN","RTH","QQQ","SPY.AU","IBB","IGM","XSD","AON.AU","PCG","SAIC","SLV","XRT","EXI","GLD","XLI","USO","XLK","SPCX","UNG","BETH","PCG.AU","IYE","FAS","AON","XLV","EETH","FAZ","BITO","SOXX","GME","IYH","IYJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD","LU1023059063.AUD","AMGN","LU2242646821.SGD","SG9999001440.SGD","BK4581","LU0058720904.USD","PJP","LU1057294990.SGD","LU1571399168.USD","BK4585","BK4566","LU2089984988.USD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","BBH","BK4533","IE0009355771.USD","BK4588","BIB","IBBQ","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663200514","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2663200514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663200514?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:04","pubTimestamp":1788181452,"startTime":"0","endTime":"0","summary":"Healthcare stocks were falling premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.5% lower and the iShares Biotechnology ETF (IBB) down 0.6%.Arrowhead Pharmaceuticals' ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","HCSG","XLV","IBB","BK4585","LU0029874061.USD","LABU","BK4139","BK4137","XBI","BK4581","ARWR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1061106388.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BBH","LU1057294990.SGD","LU2468319806.SGD","PJP","BIB","LU1571399168.USD","BK4533","SG9999001440.SGD","LU2242646821.SGD","LU0058720904.USD","IBB","LU0320765992.SGD","LU0868494617.USD","PBE","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","IE0009355771.USD","LU0122379950.USD","LU2112291526.USD","LU2242652126.USD","BK4534","LU0109394709.USD","BK4581","LU0889565916.HKD","AMGN","BK4585","LU0289739699.SGD","BK4139","IBBQ","LU1023059063.AUD","TBXU","BK4599","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4588","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0122379950.USD","TBXU","PJP","SG9999001440.SGD","IBB","LU0289739699.SGD","IE00B2B36J28.USD","BK4585","BIB","BK4533","BK4534","LU0320765992.SGD","LU2242646821.SGD","BBH","AMGN","LU0058720904.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","PBE","LU1983299246.USD","BK4139","LU2468319806.SGD","LU1061106388.HKD","BK4566","IE00B4R5TH58.HKD","LU2242652126.USD","BK4581","IE0002141913.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0868494617.USD","IBBQ","LU1057294990.SGD","LU2112291526.USD","BK4599","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663753250","title":"Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2663753250","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663753250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165205,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics Limited is a biotechnology company focused on cell-based...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","JDOC","AGNG","BBP","IBB","DARP","IEIH","LENZ","BK4139","BK4588","FWD","LNGR","BK4007","SYNB","FHLC","BK4585","XT","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","BK4585","LU0868494617.USD","LU2112291526.USD","SG9999001440.SGD","BK4139","PJP","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1571399168.USD","TBXU","LU0289739699.SGD","LU0320765992.SGD","BK4581","IBBQ","LU0889565916.HKD","LU1057294990.SGD","BK4599","IBB","LU0122379950.USD","IE0002141913.USD","IE0009355771.USD","LU1061106388.HKD","LU2089984988.USD","BK4588","PBE","BK4566","BK4534","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","BIB","LU2468319806.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B2B36J28.USD","AMGN","BBH","LU2242646821.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX","PSCH","TECB","IYH","RSPH","BMED","LABU","NVIB","SYNB","XLVX","GDOC","MRNX","TBXU","PINK","GNMX","LFSC","IEIH","MEDI","TAK","BBP","BK4585","FRTY","IBB","BK4139","IDNA","BK4007","MRNY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0234570918.USD","LU0823416689.USD","LU2468319806.SGD","BK4532","LU1066053197.SGD","BK4568","LU0289739699.SGD","LU1934455194.USD","LU0965508806.USD","TMED","LU0965509283.SGD","LU1934455863.HKD","LU2089984988.USD","SG9999015945.SGD","LU2112291526.USD","LU0114720955.EUR","BIB","BK4588","BK4550","IE00BZ1G4Q59.USD","LU1061106388.HKD","BK4566","IE00B19Z3B42.SGD","LU1934455277.USD","LU0058720904.USD","LU1585245621.USD","IE00B3T34201.USD","IBB","LU2324357040.USD","BK4578","SG9999015978.USD","IBBQ","LU0965509010.AUD","BBH","TBXU","IE00BKVL7J92.USD","LU0882574055.USD","LU1430594728.SGD","BK4139","LU1023059063.AUD","LU1839511570.USD","BMED","LU0109394709.USD","LU0122379950.USD","BK4583","GILD","BK4585","LU1066051498.USD","MEDI","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","MRNY","IEIH","RSPH","MRNX","BMED","LFSC","SYNB","TBXU","NVIB","FRTY","TECB","BK4588","PSCH","IBB","MEDI","BBP","PINK","BK4585","GNMX","LABU","GDOC","IYH","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BBP","BK4007","IYH","NVIB","IDNA","IEIH","GNMX","TECB","MRNY","BK4588","PSCH","SYNB","PINK","IBB","LFSC","MRNX","TAK","TBXU","GDOC","BMED","XLVX","BK4585","LABU","MEDI","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","TBXU","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU1674673428.USD","LU2468319806.SGD","LU0432979614.USD","LU0079474960.USD","IE00B894F039.SGD","LU2462157665.USD","LU0757428866.USD","LU1430594728.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","BIB","BK4532","BK4567","LU1778281490.HKD","LU0234570918.USD","BK4023","IE00B19Z9P08.USD","LU1674673691.USD","BK4588","GNMX","LU0061475181.USD","VRTX","IBBQ","LU0256863811.USD","IE00BJJMRZ35.SGD","BBH","IBB","IE00B19Z3B42.SGD","LU0823416689.USD","IDNA","LU1815336091.USD","IE0002141913.USD","LU2362540622.SGD","LU1069344957.HKD","LU0566484027.USD","LU0320765992.SGD","IE00BZ9MQY76.HKD","PBE","LU2236285917.USD","IE0009355771.USD","LU2324357040.USD","VERX","BK4533","SG9999001176.SGD","LU2417539215.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0058720904.USD","LU0234570918.USD","LU0859254822.USD","LU1934455194.USD","SG9999015952.SGD","SG9999015986.USD","LU1057294990.SGD","LU1934455277.USD","LU0109394709.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU2089984988.USD","LU1061106388.HKD","LU1430594728.SGD","GILD","LU0965509283.SGD","BMED","IE00BSNM7G36.USD","SG9999015945.SGD","MEDI","BK4532","LU1674673691.USD","BK4139","SG9999015978.USD","LU0823416689.USD","BK4585","LU2112291526.USD","LU1585245621.USD","LU1066053197.SGD","TBXU","LU0122379950.USD","LU0114720955.EUR","IE00BZ1G4Q59.USD","BK4566","LU1037948541.HKD","LU1571399168.USD","LU2468319806.SGD","LU1037948897.HKD","LU0320765992.SGD","LU2087621335.USD","LU0965509010.AUD","LU1674673428.USD","BK4550","IE00BKVL7J92.USD","LU0882574055.USD","TMED","IBBQ","BK4588","LU0289739699.SGD","IE00B19Z3581.USD","BK4583","LU0861579265.USD","BK4568","LU1778281490.HKD","LU2357627491.SGD","LU1023059063.AUD","LU2324357040.USD","IE0002270589.USD","LU1839511570.USD","LU1934455863.HKD","LU0965508806.USD","IBB","BK4578","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU0320765992.SGD","IE0009355771.USD","IBB","LU2242652126.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0058720904.USD","AMGN","LU2112291526.USD","04332","BK4139","BK4534","LU1057294990.SGD","BK4566","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU0868494617.USD","LU1571399168.USD","LU2089984988.USD","PJP","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","BIB","BK4585","LU0289739699.SGD","SG9999001440.SGD","BK4581","TBXU","BK4599","LU0122379950.USD","LU1023059063.AUD","BK4588","IBBQ","LU2242646821.SGD","BK4533","PBE","LU1983299246.USD","BBH","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013365","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013365","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013365?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:33","pubTimestamp":1787945609,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each shedding 0.4%.The iShares Biotechnology ETF  dropped 2.7%.In corporate news, 10x Genomics  said a Delaware federal jury awarded the company more than $4.8 million after finding that three patents held through its Scale Biosciences unit were infringed by Parse Biosciences, a subsidiary of Qiagen . 10x Genomics shares were down 5.2%, and Qiagen was shedding 1.3%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","FMED","ARKG","BK4588","LU1861559042.SGD","BK4137","HCSG","LU2125909593.SGD","LU0128526141.USD","XBI","BK4581","BK4585","LU0029874061.USD","LU2433249047.HKD","BK4121","LU0963586101.USD","LU1861558580.USD","LABU","XLV","QGEN","BK4548","TXG","LU1923622614.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}